Related Experiment Video
Updated: Jan 3, 2026
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.2K
Targeting Calcium Signalling in Malignant Mesothelioma
Simona Martinotti1,2, Mauro Patrone1, Francesco Moccia3
1DiSIT-Dipartimento di Scienze e Innovazione Tecnologica, University of Piemonte Orientale, Viale Teresa Michel 11, 15121 Alessandria, Italy.
Cancers
|November 27, 2019
Summary
Calcium ions (Ca2+) are crucial in cancer, particularly malignant mesothelioma. Targeting calcium channels offers a promising therapeutic strategy for this aggressive asbestos-related cancer.
Area of Science:
- Oncology
- Cell Biology
- Ion Channel Physiology
Background:
- Calcium ions (Ca2+) are vital signaling molecules regulating cell fate and are implicated in cancer development.
- Malignant mesothelioma, an aggressive cancer linked to asbestos exposure, has poor treatment outcomes with conventional chemotherapy.
- Altered expression and activity of Ca2+-permeable ion channels are observed in mesothelioma cells.
Purpose of the Study:
- To review the role of the calcium ion (Ca2+) signaling system in malignant mesothelioma.
- To explore the potential of Ca2+ channels as therapeutic targets for mesothelioma.
Main Methods:
- Literature review focusing on calcium signaling in cancer.
- Analysis of studies investigating ion channel expression and activity in mesothelioma.
- Examination of pharmacological modulators of Ca2+ channels.
Main Results:
- Calcium ions (Ca2+) play a central role in cancer cell signaling and proliferation.
- Specific Ca2+-permeable ion channels are dysregulated in malignant mesothelioma.
- Certain Ca2+ channels are sensitive to pharmacological agents.
Conclusions:
- The Ca2+ signaling network is integral to mesothelioma pathogenesis.
- Targeting Ca2+ channels presents a novel therapeutic avenue for malignant mesothelioma.
- Pharmacological modulation of Ca2+ channels may improve treatment strategies for mesothelioma.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:16Calmodulin-dependent Signaling
5.9K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.9K
02:38Mitogens and the Cell Cycle
7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K